17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bioprospecting endophytic fungi for bioactive metabolites and use of irradiation to improve their bioactivities

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The search for new bioactive compounds with innovative modes of action and chemistry are desperately needed to tackle the increased emergence of drug-resistant microbes. With this view, this paper was conducted for the isolation, identification, and biological evaluation of fungal endophytes of eleven different plant species. A total of 69 endophytic strains were isolated and tested for the presence of bioactive metabolites with antifungal, antibacterial, anticancer, and antioxidant properties in their extracts. Upon screening, two promising strains were found to have all the before-mentioned activities. These strains were Aspergillus sydowii isolated from the bark of Ricinus communis and Aspergillus flavus isolated from the twigs of Psidium guajava. Major compounds present in extracts of the two strains were identified by GC-Mass analyses. Several well-known bioactive compounds as well as unreported ones were identified in the fungal extracts of the two strains. Furthermore, gamma irradiation (at 1000 Gy) of the fungal cultures resulted in improved bioactivities of extracts from the two strains. These findings recommend the two fungal strains as sources of antimicrobial, anticancer, and antioxidant compounds which may aid in the development of novel drugs. The presented research also explains the high-value of fungal endophytes as untapped sources of bioactive metabolites.

          Keypoints

          • Discovery of two promising fungal endophytes with divers’ range of bioactivities

          • Extracts of the two strains showed antimicrobial, anticancer, and antioxidant activities

          • Exposure to gamma rays at 1000 Gy significantly enhanced all the bioactivities.

          Related collections

          Most cited references63

          • Record: found
          • Abstract: found
          • Article: not found

          Natural products in drug discovery: advances and opportunities

          Natural products and their structural analogues have historically made a major contribution to pharmacotherapy, especially for cancer and infectious diseases. Nevertheless, natural products also present challenges for drug discovery, such as technical barriers to screening, isolation, characterization and optimization, which contributed to a decline in their pursuit by the pharmaceutical industry from the 1990s onwards. In recent years, several technological and scientific developments — including improved analytical tools, genome mining and engineering strategies, and microbial culturing advances — are addressing such challenges and opening up new opportunities. Consequently, interest in natural products as drug leads is being revitalized, particularly for tackling antimicrobial resistance. Here, we summarize recent technological developments that are enabling natural product-based drug discovery, highlight selected applications and discuss key opportunities.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Natural Products as Sources of New Drugs from 1981 to 2014.

            This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012. In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from January 1, 1981, to December 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2014 for all approved antitumor drugs worldwide. As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixtures" now recognized as drug entities by the U.S. FDA (and similar organizations). From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well. For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small molecules approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts

                Bookmark

                Author and article information

                Contributors
                sayed_zahran2000@yahoo.com , elsayed.ramadan@eaea.org.eg
                Journal
                AMB Express
                AMB Express
                AMB Express
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                2191-0855
                19 April 2022
                19 April 2022
                2022
                : 12
                : 46
                Affiliations
                [1 ]GRID grid.429648.5, ISNI 0000 0000 9052 0245, Plant Research Department, , Nuclear Research Center, Egyptian Atomic Energy Authority, ; Cairo, Egypt
                [2 ]GRID grid.429648.5, ISNI 0000 0000 9052 0245, Biological Applications Department, , Nuclear Research Center, Egyptian Atomic Energy Authority, ; Cairo, Egypt
                [3 ]GRID grid.411660.4, ISNI 0000 0004 0621 2741, Department of Botany, and Microbiology Faculty of Science, , Benha University, ; Benha, Qalubiya Governorate, Egypt
                Author information
                http://orcid.org/0000-0001-7867-3801
                Article
                1386
                10.1186/s13568-022-01386-x
                9018947
                35438322
                d72abe81-5041-4896-a3ac-dc60efb82c93
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 30 March 2022
                : 9 April 2022
                Funding
                Funded by: Egyptian Atomic Energy Authority
                Categories
                Original Article
                Custom metadata
                © The Author(s) 2022

                Biotechnology
                bioactives,antioxidant,antifungal,antibacterial,endophytes,anticancer
                Biotechnology
                bioactives, antioxidant, antifungal, antibacterial, endophytes, anticancer

                Comments

                Comment on this article